文献速递膀胱癌与上尿路尿路上皮癌

远端输尿管节段性切除加输尿管端端吻合术与膀胱袖状切除加输尿管再植入术治疗上尿路尿路上皮癌的多中心研究结果

Segmental resection of distal ureter with termino-terminal ureteric anastomosis vs bladder cuff removal and ureteric re-implantation for upper tract urothelial carcinoma: results of a multicentre study.
PubMed 文献 · BJU Int · 2019-02-25

这项多中心回顾性研究纳入84例远端输尿管上尿路尿路上皮癌患者,比较节段性切除加端端吻合术(TT)与膀胱袖状切除加输尿管再植入术(RR)的总生存、癌特异性生存、无复发生存及术后肾功能。中位随访22.7个月,两组5年生存指标及术后肌酐变化均无显著差异。

要点

  • TT组与RR组5年总生存、癌特异性生存、无复发生存均无显著差异
  • 两组术后肌酐变化无显著差异(P=0.411)
  • 作者认为在选定病例中TT可作为安全的治疗选择

核心结论

  • 接受TT或RR治疗的远端输尿管UTUC患者总生存、癌特异性生存、无复发生存及术后肾功能相当。
  • 作者认为膀胱袖状切除在远端输尿管UTUC治疗中并非必须,TT在选定病例中可作为安全方案。

研究设计与样本

  • 多中心回顾性研究,纳入84例诊断为远端输尿管UTUC并接受TT或RR治疗的患者。
  • 521例UTUC患者中,65例(77.4%)接受RR,19例(22.6%)接受TT。
  • 主要终点为比较TT与RR的总生存、癌特异性生存和无复发生存,次要终点为比较两组术后肌酐值。

主要发现

  • 两组术前和术后特征无统计学差异,中位随访22.7个月。
  • TT组与RR组5年总生存为73.7% vs 92.3%(P=0.052),无显著差异。
  • TT组与RR组5年癌特异性生存为94.7% vs 95.4%(P=0.970),无显著差异。
  • TT组与RR组5年无复发生存为63.2% vs 53.9%(P=0.489),无显著差异。
  • 术后肌酐变化与手术方式无关(P=0.411)。

临床怎么用

  • 作者认为膀胱袖状切除在远端输尿管UTUC治疗中并非必须,TT在选定病例中可作为安全方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare overall (OS), cancer-specific (CSS), recurrence-free survival (RFS) and postoperative renal function amongst patients with upper tract urothelial carcinoma (UTUC) of the distal (lower lumbar and pelvic) ureter, electively treated with segmental resection and termino-terminal anastomosis (TT) vs bladder cuff removal and ureteric re-implantation (RR). PATIENTS AND METHODS: A multicentre retrospective study, including 84 patients diagnosed with UTUC of the distal ureter and treated with TT or RR, is presented. The primary endpoint was to compare TT and RR in terms of OS, CSS and RFS. As a secondary outcome, we compared the postoperative creatinine values as an index of renal function in the two groups. RESULTS: Of 521 patients with UTUC, 65 (77.4%) and 19 (22.6%) patients underwent RR and TT, respectively. Pre- and postoperative characteristics were not statistically different between the two groups. The median follow-up period was 22.7 months. Patients treated with TT and those treated with RR did not have significantly different 5-year OS, CSS or RFS (73.7% vs 92.3%, P = 0.052; 94.7% vs 95.4%, P = 0.970: and 63.2% vs 53.9%, P = 0.489, respectively). No difference in postoperative creatinine variation emerged in association with the surgical technique (P = 0.411). CONCLUSION: Patients treated with TT or RR for UTUC showed comparable OS, CSS, RFS and postoperative renal function. Our data suggest that bladder cuff removal is not imperative in the treatment of distal ureteric UTUC, and TT can be a safe solution in selected cases.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Abrate A, Sessa F, Sebastianelli A, et al. Segmental resection of distal ureter with termino-terminal ureteric anastomosis vs bladder cuff removal and ureteric re-implantation for upper tract urothelial carcinoma: results of a multicentre study. BJU Int. 2019. PMID: 30712313. doi:10.1111/bju.14697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。